Sanofi's experimental oral drug venglustat demonstrated significant neurological benefits for patients with Type 3 Gaucher disease in a late-stage trial, but failed to meet its primary endpoint in a separate study for Fabry disease, casting uncertainty on its regulatory path.
As transatlantic tensions simmer, a renewed push to bring home Germany's gold stored in New York vaults sparks debate over financial security, political symbolism, and Cold War-era trust.
Backed by regional sovereign wealth giants, Ruya Partners is launching a $400 million fund to address middle-market lending gaps in Saudi Arabia and the UAE, positioning itself as a key player in the Gulf's burgeoning private credit landscape.
Philippine Vice President Sara Duterte, a leading contender for the 2028 presidency, faces renewed impeachment efforts filed by civil society groups. The complaints allege corruption and abuse of public trust, deepening the political rift with President Ferdinand Marcos Jr.'s administration.
ProPublica has identified the two Customs and Border Protection officers who discharged their weapons during an encounter that resulted in the death of Alex Pretti, a 37-year-old nurse. The incident has intensified scrutiny of federal immigration enforcement tactics in urban areas.
A five-year-old boy, whose detention made him a symbol of U.S. immigration enforcement, has been released with his father. Their case highlights the ongoing political stalemate over border policy and government funding, with a partial shutdown looming.
Amid a patchy market recovery, savvy investors are scouring Europe for hidden gems. We spotlight three companies—from shipping to sportswear—whose current share prices appear significantly discounted against their intrinsic value, presenting potential opportunities for long-term growth.
Amidst a cautiously recovering Eurozone economy, we spotlight three lesser-known European companies—spanning finance, telecom, and food production—that combine strong fundamentals with compelling growth narratives for discerning investors.
As Europe's markets navigate a fragile recovery, investors are turning to dividend-paying stocks for income and resilience. We examine three companies offering attractive yields, weighing their potential against underlying financial risks.
While the UK kitchenware retailer maintains sales growth, a five-year decline in a key profitability metric and rising liabilities signal potential headwinds for investors.
The London-listed gold miner AltynGold is turning heads with a remarkable 43% return on capital employed, significantly outpacing industry averages and fueling investor optimism about its expansion potential.
A dominant 78% institutional ownership stake in Domino's Pizza Group plc underscores the company's appeal to major financial players, while raising questions about stock volatility and long-term strategy.
A fabricated email alleging Jeffrey Epstein discussed Bitcoin's launch with Ghislaine Maxwell has spread online. While the viral message is false, newly released court documents contain genuine references to the cryptocurrency's pseudonymous founder.
A Nevada court has temporarily blocked the prediction market platform Polymarket, siding with state regulators who argue its event contracts constitute illegal gambling. The ruling intensifies a global regulatory crackdown that threatens the core business model of an emerging financial sector.
The American-born pontiff has issued a public plea for peace amid reports of a covert U.S. plan to destabilize Cuba's government, marking his latest critique of Trump-era foreign policy.
In a striking departure from her once-fervent loyalty, former Congresswoman Marjorie Taylor Greene has launched a scathing critique of Donald Trump and his MAGA movement, accusing him of abandoning his base for wealthy donors and foreign interests, particularly Israel.
Deputy Attorney General Todd Blanche faced criticism from legal experts following a Sunday morning interview, during which he characterized all undocumented immigrants as criminals—a statement at odds with established Supreme Court precedent.
As voters from Japan to Brazil head to the polls in a packed electoral calendar, investors brace for potential market volatility. The outcomes could redefine fiscal policies, international alliances, and economic trajectories in a world already navigating U.S. monetary uncertainty and geopolitical strife.
Shares of security products giant Allegion have gained significant momentum, delivering a 26% total return over the past year. With the stock now trading near $165, we examine whether its current valuation still offers an attractive entry point or if future growth is already priced in.
Takeda Pharmaceutical's (TSE:4502) recent share price rally has ignited a debate among investors. With the stock closing at ¥5,242, analysts are divided on its true worth, presenting a complex picture of fair value signals and future growth prospects.
